Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cachexia | 1 | 2024 | 205 | 0.830 |
Why?
|
| Cholesterol Ester Transfer Proteins | 5 | 2007 | 113 | 0.750 |
Why?
|
| Quinolines | 7 | 2007 | 732 | 0.660 |
Why?
|
| Anticholesteremic Agents | 9 | 2018 | 979 | 0.500 |
Why?
|
| Heptanoic Acids | 6 | 2007 | 343 | 0.470 |
Why?
|
| Cholesterol, HDL | 5 | 2007 | 1813 | 0.460 |
Why?
|
| Pyrroles | 6 | 2007 | 1147 | 0.340 |
Why?
|
| Hyperlipoproteinemia Type II | 4 | 2018 | 375 | 0.270 |
Why?
|
| Cholesterol, LDL | 7 | 2018 | 2354 | 0.220 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 176 | 0.220 |
Why?
|
| Carotid Arteries | 5 | 2012 | 949 | 0.210 |
Why?
|
| Hypercholesterolemia | 3 | 2017 | 1151 | 0.200 |
Why?
|
| Atherosclerosis | 5 | 2012 | 3445 | 0.170 |
Why?
|
| Cardiology | 2 | 2021 | 1668 | 0.170 |
Why?
|
| Tunica Intima | 3 | 2012 | 463 | 0.170 |
Why?
|
| Clinical Trials as Topic | 4 | 2021 | 7908 | 0.140 |
Why?
|
| Physicians, Women | 1 | 2021 | 486 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2007 | 4576 | 0.130 |
Why?
|
| Neoplasms | 1 | 2024 | 21675 | 0.120 |
Why?
|
| Double-Blind Method | 9 | 2017 | 12020 | 0.110 |
Why?
|
| Antibodies | 2 | 2017 | 2459 | 0.100 |
Why?
|
| Leadership | 1 | 2021 | 1357 | 0.100 |
Why?
|
| Quality of Life | 3 | 2024 | 12788 | 0.100 |
Why?
|
| Indicator Dilution Techniques | 1 | 1990 | 40 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1429 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2022 | 4599 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2020 | 3740 | 0.080 |
Why?
|
| Myocardium | 4 | 1999 | 4775 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1670 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2010 | 601 | 0.070 |
Why?
|
| Professional Review Organizations | 2 | 1997 | 50 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9272 | 0.070 |
Why?
|
| Phenylalanine | 4 | 1994 | 365 | 0.070 |
Why?
|
| Mortality | 2 | 2016 | 2862 | 0.070 |
Why?
|
| Cardiovascular Diseases | 6 | 2018 | 15142 | 0.070 |
Why?
|
| Injections, Subcutaneous | 2 | 2017 | 667 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5033 | 0.060 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6487 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2007 | 875 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 850 | 0.050 |
Why?
|
| Adult | 8 | 2024 | 213889 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2007 | 851 | 0.040 |
Why?
|
| Humans | 24 | 2024 | 743811 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9975 | 0.040 |
Why?
|
| Inosine | 1 | 1999 | 133 | 0.040 |
Why?
|
| Cholesterol | 1 | 2007 | 2922 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2950 | 0.040 |
Why?
|
| Muscles | 2 | 1994 | 1613 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2007 | 5986 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2018 | 349 | 0.040 |
Why?
|
| Middle Aged | 14 | 2018 | 213241 | 0.040 |
Why?
|
| Hospitalization | 1 | 2016 | 10259 | 0.030 |
Why?
|
| Male | 18 | 2021 | 349776 | 0.030 |
Why?
|
| Muscle Proteins | 2 | 1994 | 1158 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 1997 | 240 | 0.030 |
Why?
|
| Lipids | 2 | 2017 | 3307 | 0.030 |
Why?
|
| Total Quality Management | 1 | 1996 | 274 | 0.030 |
Why?
|
| Proteins | 1 | 1990 | 6098 | 0.030 |
Why?
|
| Female | 17 | 2021 | 380020 | 0.030 |
Why?
|
| Cardiology Service, Hospital | 1 | 1996 | 246 | 0.030 |
Why?
|
| Adenosine | 1 | 1999 | 825 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2018 | 503 | 0.030 |
Why?
|
| Coronary Disease | 2 | 2007 | 6078 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9944 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 19894 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1995 | 395 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 642 | 0.030 |
Why?
|
| Tritium | 2 | 1990 | 745 | 0.030 |
Why?
|
| Scintillation Counting | 1 | 1992 | 38 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 3912 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3255 | 0.030 |
Why?
|
| Heart Failure | 1 | 2016 | 10896 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 1994 | 316 | 0.030 |
Why?
|
| Leucine | 2 | 1990 | 559 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 5983 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2617 | 0.020 |
Why?
|
| Risk Factors | 4 | 2022 | 72252 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 63042 | 0.020 |
Why?
|
| Blood Substitutes | 1 | 1990 | 58 | 0.020 |
Why?
|
| Heart Transplantation | 2 | 1995 | 3113 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2022 | 3458 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1990 | 577 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2022 | 6441 | 0.020 |
Why?
|
| Dogs | 2 | 1990 | 3911 | 0.020 |
Why?
|
| Hyperlipidemia, Familial Combined | 1 | 2007 | 10 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1996 | 2162 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6485 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1999 | 4459 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1991 | 733 | 0.020 |
Why?
|
| Aged | 8 | 2022 | 163178 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 2419 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 1574 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39001 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 1537 | 0.020 |
Why?
|
| Connecticut | 2 | 1997 | 366 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1997 | 2211 | 0.020 |
Why?
|
| Cause of Death | 1 | 2016 | 3580 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 1997 | 11708 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 1990 | 452 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1990 | 1579 | 0.020 |
Why?
|
| Medicare | 1 | 2022 | 6565 | 0.010 |
Why?
|
| United States | 2 | 2022 | 69859 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12354 | 0.010 |
Why?
|
| Hospitals | 1 | 1997 | 3953 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2123 | 0.010 |
Why?
|
| Kinetics | 1 | 1990 | 6476 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1990 | 1874 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2007 | 8551 | 0.010 |
Why?
|
| Disease Progression | 2 | 2007 | 13273 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 2803 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1991 | 3175 | 0.010 |
Why?
|
| Rabbits | 2 | 1999 | 4894 | 0.010 |
Why?
|
| Insulin | 1 | 1994 | 6584 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4561 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 1486 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 1999 | 351 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 1386 | 0.010 |
Why?
|
| Species Specificity | 1 | 1999 | 2480 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 2119 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1995 | 414 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2007 | 53250 | 0.010 |
Why?
|
| Child | 1 | 2020 | 77637 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1992 | 500 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9582 | 0.010 |
Why?
|
| Animals | 5 | 1999 | 168660 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1677 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1996 | 1503 | 0.010 |
Why?
|
| Lactates | 1 | 1990 | 431 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1992 | 675 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1999 | 3106 | 0.000 |
Why?
|
| Femoral Vein | 1 | 1987 | 159 | 0.000 |
Why?
|
| Algorithms | 1 | 2007 | 13869 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1990 | 1108 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1991 | 820 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1990 | 1131 | 0.000 |
Why?
|
| Time Factors | 2 | 1996 | 40038 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1991 | 5179 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8300 | 0.000 |
Why?
|
| Arteries | 1 | 1987 | 1119 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1995 | 2789 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1996 | 7729 | 0.000 |
Why?
|
| Amino Acids | 1 | 1987 | 1733 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 85729 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1991 | 4152 | 0.000 |
Why?
|
| Rats | 1 | 1994 | 24250 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1992 | 6259 | 0.000 |
Why?
|
| Echocardiography | 1 | 1990 | 5096 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1990 | 5002 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1991 | 15281 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1995 | 77410 | 0.000 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_